Ayala Pharmaceuticals Inc (ADXS)

[Gantor50]

I tend to agree with this. It isn't the threat of dilution that I see as the main problem, it is the prolonged and extended uncertainty which leads to normal questions about ADXS leadership.

Any dilution event would likely bring enough money in that would get them past EU approval. It might finally mark a bottom I have been hoping to see for the last 6 months now.